Search This Blog

Saturday, April 6, 2019

Amgen (AMGN) Could See $13 Benefit From NVS Breach – RBC

RBC Capital analyst Kennen MacKay reiterated a Sector Perform rating on Amgen (NASDAQ: AMGN) and sees potential for +$10-$13/share.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.